The U.S. Court of Appeals for the Federal Circuit has denied LabCorp's petition for a rehearing of a lawsuit brought by Competitive Technologies on behalf of two university clients over a homocysteine assay patent.
In a victory for Napa Valley vintners, California's Supreme Court has ruled that wines with labels bearing the Napa name must be be made largely with grapes from the region.
In a curious case that may prove your company does indeed own your thoughts, a Texas appeals court has affirmed that Alcatel owns the rights to a former employee’s business idea, even though it existed only in his head at the time of his employment.
The mere filing of an Abbreviated New Drug Application (ANDA) cannot constitute an act of willful infringement compensable by attorney’s fees under the Hatch-Waxman Act, the U.S. Court of Appeals for the Federal Circuit has ruled.
The Federal Circuit’s decision to rehear Phillips’ lawsuit against AWH Corp. en banc could lead to a full reexamination of many of its precedents on the interpretation of patent claims, patent attorneys say.
A federal appeals court has ordered the U.S. Food and Drug Administration to stay final approval of the Alpharma’s generic version of Pfizer's epilepsy treatment Neurontin pending an appeal.
Microsoft Corp. has decided to appeal a warning by Japan's Fair Trade Commission over patent-related contract provisions that the FTC says violates the Antimonopoly Law.
The University of California and Eolas have filed a brief with the U.S. Court of Appeals for the Federal Circuit to counter Microsoft's request for an appeal of a $565 jury verdict.
The Federal Circuit has upheld a lower court’s decision to invalidate a cooking patent held by ConAgra, but set aside a related $18 million antitrust award determined by the district court jury.
The U.S. Court of Appeals for the Federal Circuit has dealt biotech company Repligen a setback, ruling in favor of Bristol-Myers Squibb Co. in a dispute over the ownership of a patent for the immunosuppressant CTLA4-Ig.
The Court of Appeals for the Federal Circuit has upheld a lower court’s ruling that Abbott Laboratories did not infringe a Novartis patent for the human transplant drug cyclosporine.
Canada’s music industry has filed appeal arguments hoping to overturn a decision last March that protected the identities of people who copy music online.
In a lawsuit that reaffirms a key principle in New Zealand’s patent policy, Pfizer has lost an appeal seeking a reversal of a High Court decision that the company could not patent a method of treating psychotic disorders using a new compound.
The Federal Circuit has reversed and remanded a small California company’s lawsuit against Microsoft Corp. over patents for v-shaped ergonomic computer keyboards, raising questions about the credibility of Microsoft’s witnesses in the district court.
The U.S. Court of Appeals for the Federal Circuit has denied the University of Rochester’s request for a hearing by the court’s full panel on the validity of a patent for cox-2 inhibitors such as Pfizer’s $3 billion Celebrex drug.
The U.S. Court of Appeals for the Federal Circuit has dismissed an appeal by the University of Illinois that sought a shield of sovereign immunity from counterclaims filed by Japanese electronics maker Fujitsu in a lawsuit over patents for plasma displays.
The Supreme Court of Canada has ruled that internet service providers cannot be held accountable for digital music files transmitted over their networks, dealing a blow to the music industry’s anti-piracy efforts.
The U.S. Court of Appeal for the Federal Circuit has upheld the U.S. Patent and Trademark Office’s refusal to register the trademark “patents.com,” ruling that adding the suffix “.com” is no different than adding terms such as “”Corp.”, “Inc.”, and “Co.”
A U.S. appeals court has paved the way for Xechem International to seek treble damages in an antitrust suit against drug maker Bristol-Myers Squibb over its alleged efforts to thwart generic competition for the cancer drug Taxol.
The Second Circuit Court of Appeals had granted General Cigar’s request for a stay pending appeal of a lower court's ruling against the company in a trademark dispute over the world's most famous cigar brand.